The Journal of Steroid Biochemistry and Molecular Biology 2014-07-01

The “newer” progestogens and postmenopausal hormone therapy (HRT)

Adolf E. Schindler

Index: J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014)

Full Text: HTML

Abstract

• The “newer” progestogens have a high bioavailability. • The “newer” progestogens have a sufficient progestogenic effect. • The “newer” progestogens do not cause undue side effects. • The “newer” progestogens do not jeopardize lipid- and carbohydrate metabolism.

Related Compounds

Structure Name/CAS No. Articles
Nandrolone Structure Nandrolone
CAS:434-22-0
Nomegestrol acetate Structure Nomegestrol acetate
CAS:58652-20-3
Drospirenone Structure Drospirenone
CAS:67392-87-4